GlassScriptPhysician profile
Melanie P Mire
NPI 1710146113
$1,852.55
in general payments reported to CMS, 2019-2025
21 companies · $947 in 2025
The $947 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $170 · 2023: $126 · 2024: $427 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.39 |
| Travel and Lodging | $288.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $691.89 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Virtus Pharmaceuticals LLC | $161.38 | 2023-2025 | Levorphanol Tartrate |
| Globus Medical, INC. | $149.15 | 2025 | Senza, Vyrsa V1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.46 | 2021-2025 | Relistor |
| Boston Scientific Corporation | $100.89 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Vertos Medical, INC. | $100.70 | 2024 | Mild Device Kit |
| Tersera Therapeutics LLC | $84.45 | 2021-2023 | Prialt |
| Nevro Corp. | $69.67 | 2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $57.22 | 2024-2025 | |
| Nalu Medical, INC. | $54.54 | 2023-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $38.40 | 2024 | Sprint Pns System |
| Saluda Medical Americas, INC. | $36.56 | 2025 | Evoke |
| Bioventus LLC | $32.99 | 2025 | Xcell |
| Biodelivery Sciences International, INC. | $27.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.20 | 2023 | Seglentis |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20.78 | 2025 | Collagenase Santyl |
| Relievant Medsystems, INC. | $19.96 | 2022 | |
| Scilex Pharmaceuticals INC. | $18.78 | 2024 | |
| Almatica Pharma LLC | $18.53 | 2021 | |
| Convatec INC. | $17.35 | 2024 | |
| Curonix LLC | $16.80 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Mire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.